191 related articles for article (PubMed ID: 18022203)
21. Increased dopamine uptake in striatal synaptosomes after treatment of rats with amantadine.
Page G; Peeters M; Maloteaux JM; Hermans E
Eur J Pharmacol; 2000 Sep; 403(1-2):75-80. PubMed ID: 10969146
[TBL] [Abstract][Full Text] [Related]
22. A novel spirocyclic tropanyl-Δ²-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptake.
Dallanoce C; Canovi M; Matera C; Mennini T; De Amici M; Gobbi M; De Micheli C
Bioorg Med Chem; 2012 Nov; 20(21):6344-55. PubMed ID: 23022052
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
Barton CL; Hutson PH
Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
[TBL] [Abstract][Full Text] [Related]
24. The effect of 5-HT receptor ligands on the uptake of [3H]5-hydroxytryptamine into rat cortical synaptosomes.
Cheng CH; Costall B; Naylor RJ; Rudd JA
Eur J Pharmacol; 1993 Aug; 239(1-3):211-4. PubMed ID: 8223895
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization and visualization of the glial serotonin transporter.
Inazu M; Takeda H; Ikoshi H; Sugisawa M; Uchida Y; Matsumiya T
Neurochem Int; 2001 Jul; 39(1):39-49. PubMed ID: 11311448
[TBL] [Abstract][Full Text] [Related]
26. Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia.
Wright AM; Bempong J; Kirby ML; Barlow RL; Bloomquist JR
Brain Res; 1998 Mar; 788(1-2):215-22. PubMed ID: 9555021
[TBL] [Abstract][Full Text] [Related]
27. Methcathinone decreases dopamine transporter function: Role of protein kinase C.
Magee CP; Le BD; Siripathane YH; Wilkins DG; Hanson GR; Fleckenstein AE
J Neurochem; 2021 Oct; 159(1):116-127. PubMed ID: 34320222
[TBL] [Abstract][Full Text] [Related]
28. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
Clarke PB; Reuben M
Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
[TBL] [Abstract][Full Text] [Related]
29. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood.
Moll GH; Mehnert C; Wicker M; Bock N; Rothenberger A; Rüther E; Huether G
Brain Res Dev Brain Res; 2000 Feb; 119(2):251-7. PubMed ID: 10675775
[TBL] [Abstract][Full Text] [Related]
30. [(3)H] citalopram binding to serotonin transporter sites in minnow brains.
Gould GG; Brooks BW; Frazer A
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):203-10. PubMed ID: 17697042
[TBL] [Abstract][Full Text] [Related]
31. S-[18F]fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: evaluation in rats.
Marjamäki P; Zessin J; Eskola O; Grönroos T; Haaparanta M; Bergman J; Lehikoinen P; Forsback S; Brust P; Steinbach J; Solin O
Synapse; 2003 Jan; 47(1):45-53. PubMed ID: 12422372
[TBL] [Abstract][Full Text] [Related]
32. The contribution of low-affinity transport mechanisms to serotonin clearance in synaptosomes.
Hagan CE; Schenk JO; Neumaier JF
Synapse; 2011 Oct; 65(10):1015-23. PubMed ID: 21437992
[TBL] [Abstract][Full Text] [Related]
33. Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter.
Nightingale B; Dersch CM; Boos TL; Greiner E; Calhoun WJ; Jacobson AE; Rice KC; Rothman RB
J Pharmacol Exp Ther; 2005 Aug; 314(2):906-15. PubMed ID: 15860577
[TBL] [Abstract][Full Text] [Related]
34. Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative.
Zhou FC; Lesch KP; Murphy DL
Brain Res; 2002 Jun; 942(1-2):109-19. PubMed ID: 12031859
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.
Zhu J; Yuan Y; Midde NM; Gomez AM; Sun WL; Quizon PM; Zhan CG
J Neurovirol; 2016 Jun; 22(3):282-92. PubMed ID: 26501780
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes.
Midde NM; Gomez AM; Zhu J
J Neuroimmune Pharmacol; 2012 Sep; 7(3):629-39. PubMed ID: 22570010
[TBL] [Abstract][Full Text] [Related]
37. Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats.
Conti MM; Ostock CY; Lindenbach D; Goldenberg AA; Kampton E; Dell'isola R; Katzman AC; Bishop C
Neuropharmacology; 2014 Feb; 77():1-8. PubMed ID: 24067924
[TBL] [Abstract][Full Text] [Related]
38. Evidence for noncompetitive modulation of substrate-induced serotonin release.
Rothman RB; Baumann MH; Blough BE; Jacobson AE; Rice KC; Partilla JS
Synapse; 2010 Nov; 64(11):862-9. PubMed ID: 20842720
[TBL] [Abstract][Full Text] [Related]
39. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
Steele TD; Nichols DE; Yim GK
Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
[TBL] [Abstract][Full Text] [Related]
40. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
